Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis

ClinicalTrials.gov ID: NCT01904409

Public ClinicalTrials.gov record NCT01904409. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects With Early Decompensated Liver Cirrhosis

Study identification

NCT ID
NCT01904409
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
420 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Rifaximin SSD 40 mg IR tablet Drug
  • Rifaximin SSD 80 mg IR tablet Drug
  • Rifaximin SSD 40 mg SER tablet Drug
  • Rifaximin SSD 80 mg SER tablet Drug
  • Rifaximin SSD 80mgIR/80mgSER tablet Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2013
Primary completion
May 31, 2015
Completion
Jun 30, 2015
Last update posted
Oct 22, 2019

2013 – 2015

United States locations

U.S. sites
113
U.S. states
28
U.S. cities
97
Facility City State ZIP Site status
Salix Investigative Site Birmingham Alabama 35294
Salix Investigative Site Dothan Alabama 36305
Salix Investigative Site Mobile Alabama 36617
Salix Investigative Site Tucson Arizona 85712
Salix Investigational Site Artesia California 90701
Salix Investigational Site Bakersfield California 93301
Salix Investigational Site Chula Vista California 91910
Salix Investigational Site Coronado California 92118
Salix Investigational Site Costa Mesa California 92626
Salix Investigative Site Fresno California 93701
Salix Investigational Site La Jolla California 92037
Salix Investigative Site Los Angeles California 90033
Salix Investigational Site Monterey California 93940
Salix Investigational Site Riverside California 92377
Salix Investigational Site San Diego California 92114
Salix Investigational Site Ventura California 93003
Salix Investigational Site Englewood Colorado 80113
Salix Investigational Site Littleton Colorado 80120
Salix Investigational Site Bristol Connecticut 06035
Salix Investigational Site New Haven Connecticut 06520
Salix Investigational Site Waterbury Connecticut 06708
Salix Investigational Site Coral Gables Florida 33134
Salix Investigational Site Gainesville Florida 32610
Salix Investigative Site Hialeah Florida 33012
Salix Investigational Site Hialeah Florida 33016
Salix Investigational Site Hollywood Florida 33021
Salix Investigative Site Inverness Florida 34452
Salix Investigational Site Lake Worth Florida 33449
Salix Investigative Site Largo Florida 33777
Salix Investigative Site Maitland Florida 32751
Salix Investigational Site Miami Florida 33030
Salix Investigational Site Miami Florida 33126
Salix Investigational Site Miami Florida 33136
Salix Investigational Site Miami Springs Florida 33166
Salix Investigational Site New Port Richey Florida 34653
Salix Investigative Site Orlando Florida 32824
Salix Investigational Site Pembroke Pines Florida 33024
Salix Investigational Site Port Orange Florida 32127
Salix Investigational Site Saint Cloud Florida 34769
Salix Investigational Site Tamarac Florida 33319
Salix Investigational Site Atlanta Georgia 30309
Salix Investigative Site Atlanta Georgia 30342
Salix Investigative Site Decatur Georgia 30033
Salix Investigational Site Macon Georgia 31201
Salix Investigative Site Chicago Illinois 60612
Salix Investigative Site Maywood Illinois 75390
Salix Investigational Site Evansville Indiana 47714
Salix Investigational Site Indianapolis Indiana 46202
Salix Investigative Site Iowa City Iowa 52242
Salix Investigational Site Bowling Green Kentucky 42101
Salix Investigational Site Bastrop Louisiana 71220
Salix Investigational Site Monroe Louisiana 71201
Salix Investigational Site New Orleans Louisiana 70112
Salix Investigational Site Shreveport Louisiana 71103
Salix Investigational Site Annapolis Maryland 21401
Salix Investigational Site Baltimore Maryland 21202
Salix Investigational Site Baltimore Maryland 21228
Salix Investigational Site Chevy Chase Maryland 20815
Salix Investigational Site Hagerstown Maryland 21743
Salix Investigational Site Boston Massachusetts 02114
Salix Investigational Site Boston Massachusetts 02115
Salix Investigational Site Brockton Massachusetts 02302
Salix Investigational Site Springfield Massachusetts 01105
Salix Investigative Site Chesterfield Michigan 48047
Salix Investigational Site Wyoming Michigan 49519
Salix Investigational Site Minneapolis Minnesota 55455
Salix Investigative Site Tupelo Mississippi 38801
Salix Investigational Site Kansas City Missouri 64131
Salix Investigative Site St Louis Missouri 63110
Salix Investigational Site Marlton New Jersey 08053
Salix Investigational Site New Brunswick New Jersey 07102
Salix Investigative Site Brooklyn New York 60153
Salix Investigational Site Flushing New York 11040
Salix Investigational Site New York New York 10016
Salix Investigational Site New York New York 10032
Salix Investigational Site Rochester New York 14642
Salix Investigative Site The Bronx New York 10467
Salix Investigational Site Asheville North Carolina 28801
Salix Investigational Site Chapel Hill North Carolina 27599
Salix Investigative Site Charlotte North Carolina 28204
Salix Investigational Site Charlotte North Carolina 28207
Salix Investigational Site Fayetteville North Carolina 28304
Salix Investigational Site Wilmington North Carolina 28403
Salix Investigational Site Winston-Salem North Carolina 27103
Salix Investigative Site Cincinnati Ohio 45224
Salix Investigational Site Cincinnati Ohio 45249
Salix Investigational Site Cleveland Ohio 44195
Salix Investigative Site Dayton Ohio 45415
Salix Investigational Site Mentor Ohio 44060
Salix Investigational Site Portland Oregon 97210
Salix Investigative Site Bristol Tennessee 37620
Salix Investigational Site Chattanooga Tennessee 37421
Salix Investigational Site Nashville Tennessee 37205
Salix Investigational Site Nashville Tennessee 37211
Salix Investigative Site Arlington Texas 76012
Salix Investigational Site Austin Texas 78705
Salix Investigational Site Dallas Texas 75203
Salix Investigational Site Dallas Texas 75246
Salix Investigative Site Dallas Texas 75390
Salix Investigational Site Fort Worth Texas 76104
Salix Investigational Site Houston Texas 77005
Salix Investigational Site Houston Texas 77030
Salix Investigational Site Houston Texas 77090
Salix Investigational Site San Antonio Texas 78215
Salix Investigational Site San Antonio Texas 78229
Salix Investigational Site Bountiful Utah 84010
Salix Investigative Site Salt Lake City Utah 84132
Salix Investigational Site Charlottesville Virginia 22908
Salix Investigative Site Norfolk Virginia 23502
Salix Investigative Site Richmond Virginia 23249
Salix Investigational Site Richmond Virginia 23298
Salix Investigative Site Richland Washington 99352
Salix Investigative Site Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01904409, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01904409 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →